Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Natl India
  • Sector: Technology
  • Industry: Technology Services
  • Sub-Industry: IT Services

Celestial Biolabs Ltd

+ Add to Watchlist

CBIO:IN

71.40 INR 3.05 4.46%

As of 06:05:40 ET on 03/03/2015.

Snapshot for Celestial Biolabs Ltd (CBIO)

Open: 69.55 Day's Range: 67.00 - 72.50 Volume: 888,333
Previous Close: 68.35 52wk Range: 17.15 - 72.50 1-Yr Rtn: +286.99%

Stock Chart for CBIO

No chart data available.
  • CBIO:IN 71.40
  • 1D
  • 1M
  • 1Y
68.35
Interactive CBIO Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CBIO

Current P/E Ratio (ttm) 113.9388
Estimated P/E(-) -
Relative P/E vs. SENSEX 5.5497
Earnings Per Share (ttm) 0.6267
Est. EPS -
Est. PEG Ratio -
Market Cap (M INR) 1,149.75
Shares Outstanding (M) 16.10
30 Day Average Volume 591,774
Price/Book (mrq) 1.1274
Price/Sale (ttm) 5.2716
Dividend Indicated Gross Yield -%
Cash Dividend (INR) 0.5000
Dividend Ex-Date 09/23/2009
5 Year Dividend Growth -
Next Earnings Announcement 05/29/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CBIO

  • Revenue
  • Net Income (M/INR)
  • Profit Margin (%)

Company Profile & Key Executives for CBIO

Celestial Biolabs Ltd. develops and markets computer software and develops biopharmaceuticals. The Company markets a database with information on genes and proteins with disturbed expression, a drug design software tool, software that predicts toxicity in qualitative and quantitative terms, and a database of plants, human diseases and bioactive compounds, and develops neutraceuticals.

Aditya Narayan SinghChairman/Managing Director
More Company Profile & Key Executives for CBIO

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil